Literature DB >> 11724917

Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.

L Zecca1, D Tampellini, M Gerlach, P Riederer, R G Fariello, D Sulzer.   

Abstract

The pigmented neurones of the substantia nigra are typically lost in Parkinson's disease; however, the possible relation between neuronal vulnerability and the presence of neuromelanin has not been elucidated. Early histological studies revealed the presence of increasing amounts of neuromelanin in the substantia nigra with aging in higher mammals, showed that the neuromelanin granules are surrounded by a membrane, and comparatively evaluated the pigmentation of the substantia nigra in different animal species. Histochemical studies showed the association of neuromelanin with lipofuscins. However, systematic investigations of the structure, synthesis, and molecular interactions of neuromelanin have been undertaken only during the past decade. In these later studies, neuromelanin was identified as a genuine melanin with a strong chelating ability for iron and an affinity for compounds such as lipids, pesticides, and MPP(+). The affinity of neuromelanin for a variety of inorganic and organic toxins is consistent with a postulated protective function for neuromelanin. Moreover, the neuronal accumulation of neuromelanin during aging and the link between its synthesis and a high cytosolic concentration of catechols suggest a protective role. However, its putative neuroprotective effects could be quenched in conditions of toxin overload.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724917      PMCID: PMC1187132     

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  72 in total

1.  The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.

Authors:  B Pakkenberg; A Møller; H J Gundersen; A Mouritzen Dam; H Pakkenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

2.  Total and paramagnetic metals in human substantia nigra and its neuromelanin.

Authors:  L Zecca; H M Swartz
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1993

3.  X-ray characterization of melanins--II.

Authors:  J Cheng; S C Moss; M Eisner
Journal:  Pigment Cell Res       Date:  1994-08

Review 4.  Tyrosinase: a comprehensive review of its mechanism.

Authors:  A Sánchez-Ferrer; J N Rodríguez-López; F García-Cánovas; F García-Carmona
Journal:  Biochim Biophys Acta       Date:  1995-02-22

5.  Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: characterization by electron paramagnetic resonance spectroscopy.

Authors:  W S Enochs; M J Nilges; H M Swartz
Journal:  J Neurochem       Date:  1993-07       Impact factor: 5.372

6.  Neuromelanin of the human substantia nigra: a mixed-type melanin.

Authors:  G Odh; R Carstam; J Paulson; A Wittbjer; E Rosengren; H Rorsman
Journal:  J Neurochem       Date:  1994-05       Impact factor: 5.372

7.  The neuromelanin of the human substantia nigra.

Authors:  R Carstam; C Brinck; A Hindemith-Augustsson; H Rorsman; E Rosengren
Journal:  Biochim Biophys Acta       Date:  1991-09-23

8.  Enzymatic oxidation of dopamine: the role of prostaglandin H synthase.

Authors:  T G Hastings
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

9.  Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra.

Authors:  S Aime; M Fasano; B Bergamasco; L Lopiano; G Valente
Journal:  J Neurochem       Date:  1994-01       Impact factor: 5.372

10.  Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain.

Authors:  L Zecca; R Pietra; C Goj; C Mecacci; D Radice; E Sabbioni
Journal:  J Neurochem       Date:  1994-03       Impact factor: 5.372

View more
  53 in total

Review 1.  The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.

Authors:  Alessandra Gaeta; Robert C Hider
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 2.  Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors:  Joshua D Nosanchuk; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

3.  Bacterial melanin increases electrical activity of neurons in Substantia Nigra pars compacta.

Authors:  T R Petrosyan; V A Chavushyan; A S Hovsepyan
Journal:  J Neural Transm (Vienna)       Date:  2014       Impact factor: 3.575

Review 4.  Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.

Authors:  Rainer Knörle
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

Review 5.  Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.

Authors:  Paul J Derry; Muralidhar L Hegde; George R Jackson; Rakez Kayed; James M Tour; Ah-Lim Tsai; Thomas A Kent
Journal:  Prog Neurobiol       Date:  2019-10-08       Impact factor: 11.685

6.  Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Authors:  Robert L Haining; Travis M Jones; Aubrey Hernandez
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

Review 7.  Tyrosinase-expressing neuronal cell line as in vitro model of Parkinson's disease.

Authors:  Takafumi Hasegawa
Journal:  Int J Mol Sci       Date:  2010-03-12       Impact factor: 5.923

8.  GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.

Authors:  Anna Dzierzega-Lecznar; Slawomir Kurkiewicz; Krystyna Stepien; Ewa Chodurek; Tadeusz Wilczok; Thomas Arzberger; Peter Riederer; Manfred Gerlach
Journal:  J Am Soc Mass Spectrom       Date:  2004-06       Impact factor: 3.109

9.  Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.

Authors:  Eugene V Mosharov; Kristin E Larsen; Ellen Kanter; Kester A Phillips; Krystal Wilson; Yvonne Schmitz; David E Krantz; Kazuto Kobayashi; Robert H Edwards; David Sulzer
Journal:  Neuron       Date:  2009-04-30       Impact factor: 17.173

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.